# A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin

> **NCT02355639** · PHASE1 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 16 (actual)

## Conditions studied

- Skin and Connective Tissue Diseases

## Interventions

- **DRUG:** Clobetasol propionate 0.05 % ointment
- **DRUG:** Betamethasone dipropionate 0.064 % ointment
- **DRUG:** Petrolatum ointment

## Key facts

- **NCT ID:** NCT02355639
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02355639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02355639, "A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02355639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*